(Q35680962)

English

Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain.

scientific article published on 11 August 2011

In more languages
default for all languages
No label defined

No description defined

Statements

Trabecular bone loss after administration of the second-generation antipsychotic risperidone is independent of weight gain (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit